Hadassah

Head of Hadassah’s R & D Invited to Thailand for Royal Celebration and Conference

Wednesday, Dec 27 2017

Prof. Eyal Mishani with Princess Chulabhorn Walailak of Thailand in Bangkok

Prof. Eyal Mishani, head of Research and Development at the Hadassah Medical Organization and a professor of radiology and molecular imaging, was invited to present at the academic medical conference in Bangkok, Thailand, as part of a 60th birthday celebration for Princess Chulabhorn Walailak, a professor of biochemistry.

Prof. Mishani, a visiting professor at Chulabhorn Hospital and its affiliated Research Institute (named for the princess who initiated their formation), was the only Israeli invited to this state celebration, which was attended by dignitaries from around the world. He spoke at the conference about new, sophisticated imaging methods in the diagnosis of lung and colorectal cancers, one of his areas of expertise.

Joint research is underway between Hadassah and Chulabhorn on lung imaging using PET/CT scanning, an advanced nuclear imaging technique that combines positron emission tomography (PET) and computed tomography (CT) into one machine. A PET/CT scan reveals information about both the structure and function of cells and tissues in the body during a single imaging session.

Learn more about the Hadassah Medical Organization.

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Thursday, Aug 15 2019

Argentinian Neurosurgeon Shares His Love for Working at Hadassah

Many years ago, neurosurgeon Andrés Vargas, born in Tucumán, Argentina, chose to live in Israel and practice medicine at Hadassah Hospital Ein Kerem.

READ MORE ›
alt_text

Wednesday, Aug 14 2019

A Hadassah Cystic Fibrosis Expert Advises the Panamanian Government

Dr. Malena Cohen, a pediatric pulmonary specialist at the Hadassah Medical Organization, traveled to Panama last week to explore the idea of opening the first cystic fibrosis (CF) center there.

READ MORE ›
alt_text

Tuesday, Aug 13 2019

Alzheimer’s Further Illuminated at Hadassah with New Exclusive Imaging Agent

The Hadassah Medical Organization, through its subsidiary SRY, has contracted to be the sole Israeli agent for General Electric to produce Vizamy, the company’s new radioactive imaging agent to detect, at an early stage, amyloid plaque, which has been linked to the development of Alzheimer’s disease.

READ MORE ›
alt_text

Friday, Aug 2 2019

New Thyroid Eye Disease Clinic at Hadassah Brings Integrated Care to New Mom

Miriam, 34, had just given birth to her third child, and, unlike the joy she felt after her first two births, she felt awful.

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More